CVS Health (NYSE:CVS) Releases Quarterly Earnings Results, Beats Expectations By $0.30 EPS

CVS Health (NYSE:CVS) posted its quarterly earnings results on Wednesday. The pharmacy operator reported $1.19 earnings per share for the quarter, topping analysts’ consensus estimates of $0.89 by $0.30, Zacks reports. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. CVS Health updated its FY 2025 guidance to 5.750-6.000 EPS.

CVS Health Stock Up 14.9 %

Shares of CVS Health stock traded up $8.18 during trading hours on Wednesday, reaching $63.18. 8,888,677 shares of the company’s stock were exchanged, compared to its average volume of 12,220,979. The stock has a market cap of $79.50 billion, a P/E ratio of 16.09, a P/E/G ratio of 0.60 and a beta of 0.61. The company has a 50 day moving average of $50.61 and a two-hundred day moving average of $55.92. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. CVS Health has a fifty-two week low of $43.56 and a fifty-two week high of $80.75.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.21%. The ex-dividend date of this dividend was Thursday, January 23rd. CVS Health’s dividend payout ratio (DPR) is currently 67.51%.

Wall Street Analysts Forecast Growth

CVS has been the topic of a number of analyst reports. Truist Financial cut their price target on CVS Health from $67.00 to $60.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Edward Jones upgraded CVS Health from a “hold” rating to a “buy” rating in a report on Thursday, January 30th. Piper Sandler lowered their price target on CVS Health from $72.00 to $64.00 and set an “overweight” rating for the company in a research note on Monday, November 25th. Mizuho lowered their target price on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research note on Thursday, October 24th. Finally, Leerink Partners lifted their price target on shares of CVS Health from $51.00 to $55.00 and gave the stock a “market perform” rating in a research report on Tuesday. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $67.78.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.